» Articles » PMID: 27180112

Intricacies of Assessing the Human Microbiome in Epidemiologic Studies

Overview
Journal Ann Epidemiol
Publisher Elsevier
Specialty Public Health
Date 2016 May 16
PMID 27180112
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In the past decade, remarkable relationships have been documented between dysbiosis of the human microbiota and adverse health outcomes. This review seeks to highlight some of the challenges and pitfalls that may be encountered during all stages of microbiota research, from study design and sample collection, to nucleic acid extraction and sequencing, and bioinformatic and statistical analysis.

Methods: Literature focused on human microbiota research was reviewed and summarized.

Results: Although most studies have focused on surveying the composition of the microbiota, fewer have explored the causal roles of these bacteria, archaea, viruses, and fungi in affecting disease states. Microbiome research is in its relatively early years and many aspects remain challenging, including the complexity and personalized aspects of microbial communities, the influence of exogenous and often confounding factors, the need to apply fundamental principles of ecology and epidemiology, the necessity for new software tools, and the rapidly evolving genomic, technological, and analytical landscapes.

Conclusions: Incorporating human microbiome research in large epidemiologic studies will soon help us unravel the intricate relationships that we have with our microbial partners and provide interventional opportunities to improve human health.

Citing Articles

Examining the healthy human microbiome concept.

Joos R, Boucher K, Lavelle A, Arumugam M, Blaser M, Claesson M Nat Rev Microbiol. 2024; 23(3):192-205.

PMID: 39443812 DOI: 10.1038/s41579-024-01107-0.


The salivary microbiome as a diagnostic biomarker of periodontitis: a 16S multi-batch study before and after the removal of batch effects.

Regueira-Iglesias A, Suarez-Rodriguez B, Blanco-Pintos T, Relvas M, Alonso-Sampedro M, Balsa-Castro C Front Cell Infect Microbiol. 2024; 14:1405699.

PMID: 39071165 PMC: 11272481. DOI: 10.3389/fcimb.2024.1405699.


A Narrative Review Discussing the Obstetric Repercussions Due to Alterations of Personalized Bacterial Sites Developed within the Vagina, Cervix, and Endometrium.

Doroftei B, Ilie O, Armeanu T, Stoian I, Anton N, Babici R J Clin Med. 2023; 12(15).

PMID: 37568471 PMC: 10419759. DOI: 10.3390/jcm12155069.


In silico evaluation and selection of the best 16S rRNA gene primers for use in next-generation sequencing to detect oral bacteria and archaea.

Regueira-Iglesias A, Vazquez-Gonzalez L, Balsa-Castro C, Vila-Blanco N, Blanco-Pintos T, Tamames J Microbiome. 2023; 11(1):58.

PMID: 36949474 PMC: 10035280. DOI: 10.1186/s40168-023-01481-6.


Stability of the Fecal and Oral Microbiome over 2 Years at -80°C for Multiple Collection Methods.

Zouiouich S, Byrd D, Hua X, Karwa S, Wan Y, Shi J Cancer Epidemiol Biomarkers Prev. 2023; 32(3):444-451.

PMID: 36649143 PMC: 10498478. DOI: 10.1158/1055-9965.EPI-22-0883.


References
1.
Corless C, Guiver M, Borrow R, Edwards-Jones V, Kaczmarski E, Fox A . Contamination and sensitivity issues with a real-time universal 16S rRNA PCR. J Clin Microbiol. 2000; 38(5):1747-52. PMC: 86577. DOI: 10.1128/JCM.38.5.1747-1752.2000. View

2.
Foxman B, Riley L . Molecular epidemiology: focus on infection. Am J Epidemiol. 2001; 153(12):1135-41. DOI: 10.1093/aje/153.12.1135. View

3.
Chou H, Holmes M . DNA sequence quality trimming and vector removal. Bioinformatics. 2001; 17(12):1093-104. DOI: 10.1093/bioinformatics/17.12.1093. View

4.
Grahn N, Olofsson M, Ellnebo-Svedlund K, Monstein H, Jonasson J . Identification of mixed bacterial DNA contamination in broad-range PCR amplification of 16S rDNA V1 and V3 variable regions by pyrosequencing of cloned amplicons. FEMS Microbiol Lett. 2003; 219(1):87-91. DOI: 10.1016/S0378-1097(02)01190-4. View

5.
Ott S, Musfeldt M, Wenderoth D, Hampe J, Brant O, Folsch U . Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004; 53(5):685-93. PMC: 1774050. DOI: 10.1136/gut.2003.025403. View